4.8 Article

Polyamine depletion inhibits the autophagic response modulating Trypanosoma cruzi infectivity

期刊

AUTOPHAGY
卷 9, 期 7, 页码 1080-1093

出版社

TAYLOR & FRANCIS INC
DOI: 10.4161/auto.24709

关键词

autophagy; polyamines; Trypanosoma cruzi; spermidine; DFMO; autophagic response; LC3; ATG5

资金

  1. Comision Nacional Salud Investiga (Ministerio de Salud de la Nacion)
  2. CONICET-Fundacion Fulbright
  3. Secretaria de Ciencia, Tecnica y Posgrado (Sectyp, Universidad Nacional de Cuyo)
  4. Fundacion Bunge y Born
  5. Agencia Nacional de Promocion Cientifica y Tecnologica (PICT) [2008 2235, 2008 0192]

向作者/读者索取更多资源

Autophagy is a cell process that in normal conditions serves to recycle cytoplasmic components and aged or damaged organelles. The autophagic pathway has been implicated in many physiological and pathological situations, even during the course of infection by intracellular pathogens. Many compounds are currently used to positively or negatively modulate the autophagic response. Recently it was demonstrated that the polyamine spermidine is a physiological inducer of autophagy in eukaryotic cells. We have previously shown that the etiological agent of Chagas disease, the protozoan parasite Trypanosoma cruzi, interacts with autophagic compartments during host cell invasion and that preactivation of autophagy significantly increases host cell colonization by this parasite. In the present report we have analyzed the effect of polyamine depletion on the autophagic response of the host cell and on T. cruzi infectivity. Our data showed that depleting intracellular polyamines by inhibiting the biosynthetic enzyme ornithine decarboxylase with difluoromethylornithine (DFMO) suppressed the induction of autophagy in response to starvation or rapamycin treatment in two cell lines. This effect was associated with a decrease in the levels of LC3 and ATG5, two proteins required for autophagosome formation. As a consequence of inhibiting host cell autophagy, DFMO impaired T. cruzi colonization, indicating that polyamines and autophagy facilitate parasite infection. Thus, our results point to DFMO as a novel autophagy inhibitor. While other autophagy inhibitors such as wortmannin and 3-methyladenine are nonspecific and potentially toxic, DFMO is an FDA-approved drug that may have value in limiting autophagy and the spread of the infection in Chagas disease and possibly other pathological settings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据